Despite Zoetis' underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish ...

These two stocks come from completely different industries, but each could boost a long-term investor's returns.

Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected to advance at a ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...

In addition to TD Cowen, Zoetis also received a Buy from William Blair’s Brandon Vazquez in a report issued today. However, on July 31, Stifel Nicolaus maintained a Hold rating on Zoetis (NYSE: ZTS).

Highlights,Zoetis exceeded earnings expectations,Reported earnings per share rose year-over-year,Showed steady growth compared to the previous quarter,Zoetis (NYSE:ZTS), a global leader in animal ...

Ex-Fox News Host Confirmed by Senate in 50-45 Vote Ozzy Osbourne’s cause of death revealed after rock legend’s funeral Army ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

Zoetis (ZTS) stock is in focus after reporting earnings. Zoetis CFO Wetteny Joseph joins Market Catalysts to discuss the ...

Zoetis (ZTS) stock surges premarket as the company posts strong Q2 2025 results and raises full-year outlook. Read more here.